Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Malik Khuwaja"'
Autor:
Thamer A. Almangour, Ahmad Aljabri, Mohammed Al Musawa, Abdullah Almohaizeie, Sara Almuhisen, Nader Damfu, Awaly Alfozan, Basem M. Alraddadi, Majda Alattas, Mohammed Qutub, Abrar F. Alhameed, Malik Khuwaja, Ahlam Alghamdi, Khalifa M. Binkhamis, Wafa Alfahad, Fatimah S. AlShahrani
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 288-294 (2022)
ABSTRACT: Objectives: The aim of this study was to compare the safety and effectiveness of ceftolozane-tazobactam (C-T) to colistin-based regimen for treating infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa. Methods: This was a
Externí odkaz:
https://doaj.org/article/8cc7bf460bc04587a8c8c945a2b28dbe
Autor:
Yahya A. Mohzari, Ahmad Alamer, Majda Alattas, Ahmed A. Alrashed, Nura A. Alshehab, Turkiah K. Alkhaldi, Amnah A. Alamer, Syed M.B Asdaq, Doaa Aljefri, Hamdan N. Alajami, Yazed S. Alsowaida, Maya Mathew, Mohammed I. AlMusawa, Mukhtar Alomar, Raghad Y. Alharbi, Malik Khuwaja, Reem F. Bamogaddam, Ashwaq H. Alharthi, Aisha Y. Faqihi, Bashayer F. Alrumayyan, Abeer Alshareef, Batool M. Alhassan, Nader Y. Damfu, Ghada S. Alajmi, Asma Albujaidy, Maram Alghalbi, Saleh A Alajlan, Ivo Abraham, Abdulaziz S. Almulhim
This study aimed to evaluate the effectiveness of tocilizumab in mechanically ventilated patients with coronavirus disease 2019 (COVID-19). This retrospective multicenter study included adults (≥18 years) diagnosed with severe acute respiratory syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1223fa7424b6b9290d1cbdc45a10c7
Autor:
Thamer A. Almangour, Ahmad Aljabri, Mohammed Al Musawa, Abdullah Almohaizeie, Sara Almuhisen, Nader Damfu, Awaly Alfozan, Basem M. Alraddadi, Majda Alattas, Mohammed Qutub, Abrar F. Alhameed, Malik Khuwaja, Ahlam Alghamdi, Khalifa M. Binkhamis, Wafa Alfahad, Fatimah S. AlShahrani
Publikováno v:
Journal of global antimicrobial resistance. 28
The aim of this study was to compare the safety and effectiveness of ceftolozane-tazobactam (C-T) to colistin-based regimen for treating infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa.This was a retrospective, multicentre, obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6720c2e6777ac0dc2b29b24b0cd066d
https://pubmed.ncbi.nlm.nih.gov/35121161
https://pubmed.ncbi.nlm.nih.gov/35121161